Valuation: Zai Lab Limited

Market Cap 2.87B 2.48B 2.33B 2.12B 3.99B 275B 4.05B 27.36B 10.72B 138B 10.78B 10.54B 458B P/E 2026 *
-11.3x
P/E 2027 * -11.9x
Enterprise Value 2.41B 2.08B 1.96B 1.78B 3.35B 231B 3.4B 23B 9.01B 116B 9.06B 8.86B 385B EV / Sales 2026 *
5.71x
EV / Sales 2027 * 4.38x
Free-Float
94.05%
Yield 2026 *
-
Yield 2027 * -
1 day-0.27%
1 week-1.65%
Current month+39.96%
1 month+26.58%
3 months+35.58%
6 months+26.71%
Current year+44.95%
1 week 24.64
Extreme 24.64
26.38
1 month 17.92
Extreme 17.92
26.66
Current year 15.96
Extreme 15.96
26.66
1 year 15.96
Extreme 15.96
35.45
3 years 13.48
Extreme 13.48
44.34
5 years 13.48
Extreme 13.48
152.82
10 years 13.48
Extreme 13.48
193.54
Manager TitleAgeSince
Chief Executive Officer 61 01/04/2014
Director of Finance/CFO 58 07/07/2023
President 62 01/12/2022
Director TitleAgeSince
Chairman 61 01/04/2014
Director/Board Member 83 01/01/2017
Director/Board Member 75 01/01/2017
Date Insider Type Main position Quantity % Market Cap.
12/8/26 Sell

Director

-8,506 0.0007%
11/8/26 Sell

Chief Financial Officer

-619 0.0001%
2/7/26 Other

Chief Executive Officer

-43,480 0.0038%
Change 5-day change 1-year change 3-year change Capi.($)
-0.27%-1.65%-28.36%+12.54% 2.87B
+0.53%+1.66%+41.18%-0.27% 80.91B
-1.10%-4.85%-3.14%+29.15% 50.13B
+0.32%-1.71%+13.25%+167.48% 47.97B
+5.49%+20.25%-26.17%-37.62% 53.62B
+1.63%+4.25%+56.39%-18.61% 31.41B
-2.33%+3.95%+124.14%-38.04% 25.14B
-0.02%+1.98%+45.40%+92.80% 25.03B
+1.66%+2.83%+0.51%+215.41% 21.45B
+0.99%+5.53%+68.00%+128.75% 16.93B
Average +0.69%+2.19%+29.12%+55.16% 35.54B
Weighted average by Cap. +0.96%+2.39%+26.77%+42.41%

Financials

2026 *2027 *
Net sales 423M 365M 343M 312M 587M 40.49B 596M 4.03B 1.58B 20.25B 1.59B 1.55B 67.46B 569M 491M 462M 420M 790M 54.51B 802M 5.42B 2.13B 27.26B 2.14B 2.09B 90.8B
Net income -245M -212M -199M -181M -340M -23.48B -345M -2.34B -915M -11.74B -920M -900M -39.11B -187M -161M -152M -138M -260M -17.91B -263M -1.78B -698M -8.96B -702M -687M -29.83B
Net Debt -458M -395M -372M -338M -636M -43.85B -645M -4.36B -1.71B -21.93B -1.72B -1.68B -73.05B -381M -329M -309M -281M -529M -36.49B -537M -3.63B -1.42B -18.25B -1.43B -1.4B -60.79B
Logo Zai Lab Limited
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Employees
1,784
Date Price Change Volume
18/08/26 USD 25.57 -0.27% 1,630,983
17/08/26 USD 25.64 -1.00% 1,359,116
14/08/26 USD 25.90 -0.50% 1,234,060
13/08/26 USD 26.03 +2.12% 1,042,216
12/08/26 USD 25.49 -1.96% 2,182,416
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
25.57USD
Average target price
32.39USD
Spread / Average Target
+26.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ZLAB Stock